Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Avan

Showing results (51-60 of 462) with videos related to

Pageof 47
Sort By:
Pathology, Research and Practice|June 15, 2020
Therapeutic potential of renin angiotensin system inhibitors in cancer cells metastasisMilad Hashemzehi, Farimah Beheshti, Seyed Mahdi Hassanian, et al.
Journal of Cellular Physiology|January 27, 2019
Role of TGF-β signaling regulatory microRNAs in the pathogenesis of colorectal cancerAtena Soleimani, Majid Khazaei, Gordon A Ferns, et al.
Journal of Cellular Physiology|April 14, 2017
The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancerAfsane Bahrami, AmirReza Hesari, Majid Khazaei, et al.
Current Pharmaceutical Design|January 15, 2019
Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal CancerAtena Soleimani, Farzad Rahmani, Gordon A Ferns, et al.
Journal of Cellular Physiology|November 25, 2018
The role of HSP27 in the development of drug resistance of gastrointestinal malignancies: Current status and perspectivesAtena Soleimani, Mohammad Jalili-Nik, Amir Avan, et al.
Journal of Cellular Biochemistry|January 31, 2017
Interferon-Mediated Tumor Resistance to Oncolytic VirotherapySafieh Ebrahimi, Elnaz Ghorbani, Majid Khazaei, et al.
The Journal of Pharmacy and Pharmacology|October 6, 2017
Therapeutic potency of heat-shock protein-90 pharmacological inhibitors in the treatment of gastrointestinal cancer, current status and perspectivesNadia Boroumand, Hossein Saghi, Amir Avan, et al.
Current Pharmaceutical Design|January 15, 2019
The Prognostic and Predictive Value of microRNAs in Patients with H. pylori-positive Gastric CancerSeyed Mostafa Parizadeh, Reza Jafarzadeh-Esfehani, Amir Avan, et al.
Infectious Disorders Drug Targets|March 1, 2021
A Mini Review on the Pathogenesis, Diagnosis and Treatment Options for COVID-19Farzad Rahmani, Aghigh Ziaeemehr, Sajede Alijannejad, et al.
Current Pharmaceutical Design|January 23, 2025
Therapeutic Potential of Menstrual Blood-Derived Stem Cells in Attenuating Uterine Adhesion: Novel Strategies and Future ProspectYasamin Rajabloo, Abdulridha Mohammed Al-Asady, Amir Avan, et al.
Pageof 47

Showing results (51-60 of 462) with videos related to

Sort By:
Pageof 47
Pathology, Research and Practice|June 15, 2020
Therapeutic potential of renin angiotensin system inhibitors in cancer cells metastasisMilad Hashemzehi, Farimah Beheshti, Seyed Mahdi Hassanian, et al.
Journal of Cellular Physiology|January 27, 2019
Role of TGF-β signaling regulatory microRNAs in the pathogenesis of colorectal cancerAtena Soleimani, Majid Khazaei, Gordon A Ferns, et al.
Journal of Cellular Physiology|April 14, 2017
The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancerAfsane Bahrami, AmirReza Hesari, Majid Khazaei, et al.
Current Pharmaceutical Design|January 15, 2019
Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal CancerAtena Soleimani, Farzad Rahmani, Gordon A Ferns, et al.
Journal of Cellular Physiology|November 25, 2018
The role of HSP27 in the development of drug resistance of gastrointestinal malignancies: Current status and perspectivesAtena Soleimani, Mohammad Jalili-Nik, Amir Avan, et al.
Journal of Cellular Biochemistry|January 31, 2017
Interferon-Mediated Tumor Resistance to Oncolytic VirotherapySafieh Ebrahimi, Elnaz Ghorbani, Majid Khazaei, et al.
The Journal of Pharmacy and Pharmacology|October 6, 2017
Therapeutic potency of heat-shock protein-90 pharmacological inhibitors in the treatment of gastrointestinal cancer, current status and perspectivesNadia Boroumand, Hossein Saghi, Amir Avan, et al.
Current Pharmaceutical Design|January 15, 2019
The Prognostic and Predictive Value of microRNAs in Patients with H. pylori-positive Gastric CancerSeyed Mostafa Parizadeh, Reza Jafarzadeh-Esfehani, Amir Avan, et al.
Infectious Disorders Drug Targets|March 1, 2021
A Mini Review on the Pathogenesis, Diagnosis and Treatment Options for COVID-19Farzad Rahmani, Aghigh Ziaeemehr, Sajede Alijannejad, et al.
Current Pharmaceutical Design|January 23, 2025
Therapeutic Potential of Menstrual Blood-Derived Stem Cells in Attenuating Uterine Adhesion: Novel Strategies and Future ProspectYasamin Rajabloo, Abdulridha Mohammed Al-Asady, Amir Avan, et al.
Pageof 47